Literature DB >> 25342643

Flaxseed for hypertension: implications for blood pressure regulation.

Stephanie P B Caligiuri1, Andrea L Edel, Michel Aliani, Grant N Pierce.   

Abstract

Hypertension is the single largest risk factor attributed to mortality in the world. Medications are the primary treatment for hypertension; however, adherence to drug regimens is low (~50 %). Low adherence may be a contributing factor leading to uncontrolled blood pressure in patients. An effective alternative or complement to medications in managing hypertension is through lifestyle modifications. Adopting a healthy diet is a valuable strategy. A recent, randomized controlled year-long trial observed impressive reductions in blood pressure in patients with hypertension consuming flaxseed daily. Therefore, attention has been garnered for flaxseed as a potentially valuable strategy for the management of hypertension. This review will highlight the recent data for flaxseed and its extracts in blood pressure regulation in both animal models and clinical trials. Insight into the proposed anti-hypertensive mechanism of flaxseed and the implications of flaxseed as a potential global anti-hypertensive therapy will be discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25342643     DOI: 10.1007/s11906-014-0499-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  69 in total

1.  Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.

Authors:  Paula Trumbo; Sandra Schlicker; Allison A Yates; Mary Poos
Journal:  J Am Diet Assoc       Date:  2002-11

2.  Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone.

Authors:  D D Kitts; Y V Yuan; A N Wijewickreme; L U Thompson
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

3.  The effects of flaxseed dietary supplement on lipid profile, bone mineral density, and symptoms in menopausal women: a randomized, double-blind, wheat germ placebo-controlled clinical trial.

Authors:  S Dodin; A Lemay; H Jacques; F Légaré; J-C Forest; B Mâsse
Journal:  J Clin Endocrinol Metab       Date:  2004-12-21       Impact factor: 5.958

4.  Dietary supplementation with flaxseed oil lowers blood pressure in dyslipidaemic patients.

Authors:  G K Paschos; F Magkos; D B Panagiotakos; V Votteas; A Zampelas
Journal:  Eur J Clin Nutr       Date:  2007-01-31       Impact factor: 4.016

5.  Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERalpha transcriptional activation in human breast cancer cells.

Authors:  Charlotte Carreau; Gilles Flouriot; Catherine Bennetau-Pelissero; Mylène Potier
Journal:  J Steroid Biochem Mol Biol       Date:  2008-04-04       Impact factor: 4.292

6.  Dietary protein level interacts with omega-3 polyunsaturated fatty acid deficiency to induce hypertension.

Authors:  Denovan P Begg; Andrew J Sinclair; Lauren A Stahl; Manohar L Garg; Mark Jois; Richard S Weisinger
Journal:  Am J Hypertens       Date:  2009-11-05       Impact factor: 2.689

7.  Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions.

Authors:  Chantal M C Dupasquier; Elena Dibrov; Annette L Kneesh; Paul K M Cheung; Kaitlin G Y Lee; Helen K Alexander; Behzad K Yeganeh; Mohammed H Moghadasian; Grant N Pierce
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-07-06       Impact factor: 4.733

8.  Antioxidant activities of the flaxseed lignan secoisolariciresinol diglucoside, its aglycone secoisolariciresinol and the mammalian lignans enterodiol and enterolactone in vitro.

Authors:  Chun Hu; Yvonne V Yuan; David D Kitts
Journal:  Food Chem Toxicol       Date:  2007-06-02       Impact factor: 6.023

9.  Flax lignan complex slows down the progression of atherosclerosis in hyperlipidemic rabbits.

Authors:  Kailash Prasad
Journal:  J Cardiovasc Pharmacol Ther       Date:  2009-03       Impact factor: 2.457

10.  No evidence of hypoglycemia or hypotension in older adults during 6 months of flax lignan supplementation in a randomized controlled trial: a safety evaluation.

Authors:  Jennifer Billinsky; Riley A Glew; Stephen M Cornish; Susan J Whiting; Lilian U Thorpe; Jane Alcorn; Lisa Paus-Jenssen; Thomas Hadjistavropoulos; Philip D Chilibeck
Journal:  Pharm Biol       Date:  2013-04-11       Impact factor: 3.503

View more
  8 in total

1.  Flaxseed as an Anticardiotoxicity Agent in Breast Cancer Therapy.

Authors:  Ghassan Bkaily; Danielle Jacques
Journal:  J Nutr       Date:  2020-09-01       Impact factor: 4.798

Review 2.  Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses.

Authors:  Claudio Borghi; Arrigo F G Cicero
Journal:  Br J Clin Pharmacol       Date:  2016-03-15       Impact factor: 4.335

3.  The effect of flaxseed dose on circulating concentrations of alpha-linolenic acid and secoisolariciresinol diglucoside derived enterolignans in young, healthy adults.

Authors:  Andrea L Edel; Amanda F Patenaude; Melanie N Richard; Elena Dibrov; J Alejandro Austria; Harold M Aukema; Grant N Pierce; Michel Aliani
Journal:  Eur J Nutr       Date:  2015-03-26       Impact factor: 5.614

Review 4.  A systematic review and meta-analysis of clinical trials investigating the effects of flaxseed supplementation on plasma C-reactive protein concentrations.

Authors:  Sorin Ursoniu; Amirhossein Sahebkar; Maria-Corina Serban; Iulia Pinzaru; Cristina Dehelean; Lavinia Noveanu; Jacek Rysz; Maciej Banach
Journal:  Arch Med Sci       Date:  2018-12-30       Impact factor: 3.318

Review 5.  Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets.

Authors:  S Franklyn De Silva; Jane Alcorn
Journal:  Pharmaceuticals (Basel)       Date:  2019-05-05

6.  Effect of Flaxseed Powder on Cardiovascular Risk Factor in Dyslipidemic and Hypertensive Patients.

Authors:  Naemeh Haghighatsiar; Gholamreza Askari; Sahar Saraf-Bank; Avat Feizi; Hasan Keshmiri
Journal:  Int J Prev Med       Date:  2019-12-10

7.  Combination therapy of flaxseed and hesperidin enhances the effectiveness of lifestyle modification in cardiovascular risk control in prediabetes: a randomized controlled trial.

Authors:  Zahra Yari; Zahra Naser-Nakhaee; Elahe Karimi-Shahrbabak; Makan Cheraghpour; Mehdi Hedayati; Seyede Marjan Mohaghegh; Shahrzad Ommi; Azita Hekmatdoost
Journal:  Diabetol Metab Syndr       Date:  2021-01-06       Impact factor: 3.320

8.  Influence of oral administration of kukoamine A on blood pressure in a rat hypertension model.

Authors:  Christine A Butts; Duncan I Hedderley; Sheridan Martell; Hannah Dinnan; Susanne Middlemiss-Kraak; Barry J Bunn; Tony K McGhie; Ross E Lill
Journal:  PLoS One       Date:  2022-05-06       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.